PMDA drug package insert
ベルフェミン
PMDA OTC drug · ゼリア新薬工業（株） · package insert Dec 11, 2025
Key facts
| Brand names | ベルフェミン |
|---|---|
| Companies | 製造販売元／ゼリア新薬工業（株） |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | カプセル |
| OTC effect category | 生薬製剤（他の薬効群に属さない製剤） |
| Package insert date | Dec 11, 2025 |
| PMDA document key | 380077_J2101000150 |
| PMDA company code | 380077 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: